BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 3:16:00 PM | Browse: 1120 | Download: 1105
 |
Received |
|
2013-04-04 20:26 |
 |
Peer-Review Started |
|
2013-04-05 01:03 |
 |
To Make the First Decision |
|
2013-05-02 09:00 |
 |
Return for Revision |
|
2013-05-13 15:31 |
 |
Revised |
|
2013-05-23 04:04 |
 |
Second Decision |
|
2013-07-05 10:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-07-05 12:48 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-07-17 17:45 |
 |
Publish the Manuscript Online |
|
2013-08-02 13:56 |
Category |
Radiology, Nuclear Medicine & Medical Imaging |
Manuscript Type |
Autobiography |
Article Title |
Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Matthias C Roethke, Timur H Kuru, Alexander Radbruch, Boris Hadaschik and Heinz-Peter Schlemmer |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Matthias C Roethke, MD, Department of Radiology, German Cancer Research Center Heidelberg (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. m.roethke@dkfz-heidelberg.de |
Key Words |
Butylscopolamine; Buscopan; Motion artefacts; Magnetic resonance imaging; Prostate cancer; 3 Tesla |
Core Tip |
The study demonstrated no significant effect of hyoscine-N-butyl-bromide (HBB) (butylscopolamine) administration on image quality of prostate magnetic resonance imaging (MRI) at 3.0 Tesla without using an endorectal coil. The results suggest that the use of HBB is not generally mandatory for MRI of the prostate. |
Publish Date |
2013-08-02 13:56 |
Citation |
Roethke MC, Kuru TH, Radbruch A, Hadaschik B, Schlemmer HP. Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory? World J Radiol 2013; 5(7): 259-263 |
URL |
http://www.wjgnet.com/1949-8470/full/v5/i7/259.htm |
DOI |
http://dx.doi.org/10.4329/wjr.v5.i7.259 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345